Medicare enacted 10 negotiated drug prices for some of the nation’s costliest prescription medications Jan. 1. However, years before the new prices launched, pharmaceutical companies widely altered their pricing strategies, according to a Dec. 18 Vizient report. The Inflation Reduction…
Pharmacy
As the U.S. confronts one of its most severe flu seasons, Tamiflu, a common antiviral medication to treat influenza, is in shortage in pockets across the country, Bloomberg reported Jan. 7. In Utah, where flu activity is high, pharmacists are…
GoodRx has named 20 medications and vaccines as the most influential FDA approvals of 2025, spotlighting first-in-class drugs, new indications, and therapies with the potential to significantly affect public health. 1. Nereus (tradipitant) for motion sickness: Approved Dec. 30, Nereus…
As drug pricing pressure intensifies and benefit structures shift, some health systems are still treating biosimilars as a selective cost lever — deploying them in certain payer segments while preserving legacy models elsewhere. Geisinger made a different call. Rather than…
Philadelphia-based Jefferson Health and Thomas Jefferson University filed a federal lawsuit Dec. 30 alleging that three insulin manufacturers and the nation’s largest pharmacy benefit managers conspired to inflate insulin prices, costing the health system millions. The complaint, filed in the…
Advertisement
Vera Therapeutics received priority review from the FDA for its biologics license application for atacicept to treat adults with immunoglobulin A nephropathy. The application was submitted under the FDA’s accelerated approval program and assigned a Prescription Drug User Fee Act…
For pharmacy leaders, the path to growth is no longer defined by volume alone. It hinges on access, speed, automation and trust — especially as reimbursement tightens and regulatory uncertainty mounts. That reality is shaping strategy at Boise, Idaho-based St.…
Indiana Attorney General Todd Rokita has filed a lawsuit against Eli Lilly, alleging the company contributed to inflated insulin prices over the past decade. The state is seeking injunctive relief, damages and penalties for what it describes as deceptive market…
Amneal Pharmaceuticals received FDA approval for two denosumab biosimilars referencing Prolia and Xgeva. The approval, announced Dec. 22, covers Boncresa (denosumab-mobz) and Oziltus (denosumab-mobz), both used to treat conditions related to bone loss and cancer. The drugs are administered by…
The CDC will revise the U.S. childhood immunization schedule for the first time in decades, reducing routine recommendations from 18 to 11 diseases, following a December directive from President Donald Trump to compare U.S. vaccine practices with those in peer…